Here we focus on the ubiquitously expressed dynamin 2 (DNM2) and characterize the skeletal muscle-specific function of its different isoforms and their modulation as a therapeutic target in a congenital myopathy. The gene discussed is DNM2; the disease is congenital myopathy.